Unlike Wegovy, Ozempic is FDA approved for the treatment of Type 2 diabetes, not weight loss, although healthcare providers may prescribe it off-label for weight loss
Additionally, Aetna may offer coverage with the necessary clinical documentation
The FDA has only approved Rybelsus to: Improve blood sugar control in adults with type 2 diabetes, along with diet and exercise Reduce the risk of major cardiovascular events like heart attack or stroke in adults with type 2 diabetes Research on Rybelsus and weight loss in non-diabetic patients Most of the research on Rybelsus for weight loss has been conducted in people with type 2 diabetes, since its a diabetes medication
However, systemic clinical trials specifically designed to test this combination remain limited, reflecting the relatively recent popularity of dual-pathway optimization
Compound movements like squats, deadlifts, push-ups, and overhead presses work multiple muscle groups and give you the most return for your effort
What is the SURMOUNT-5 trial
